Open AccessMP14-16 EFFICACY OF NIVOLUMAB PLUS IPILIMUMAB IN PRIMARY TUMOR AS FIRST-LINE THERAPY IN THE PATIENTS WITH ADVANCED RENAL CELL CARCINOMA
Author(s) -
Hiroshi Kojima,
Takahiro Osawa,
Ryuji Matsumoto,
Takashige Abe,
Satoru Maruyama,
Toru Harabayashi,
Haruka Miyata,
Akira Kashiwagi,
Ataru Sazawa,
Riyo Fukui,
Ken Morita,
Ichiro Takeuchi,
Noboru Yamashita,
Keita Minami,
T Mochizuki,
Nobuo Shinohara
Publication year - 2021
Publication title -
the journal of urology/the journal of urology
Language(s) - English
Resource type - Journals
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1097/ju.0000000000001995.16
Subject(s) - medicine , nivolumab , ipilimumab , renal cell carcinoma , nephrectomy , oncology , cancer , immunotherapy , kidney